GP-Act III Acquisition Corp（GPAT）の株式分析

AI analysis of GP-Act III Acquisition Corp (GPAT)

sell

Currently, GP-Act III Acquisition Corp. is not a good buy. The stock's current price is 10.95, and it has a relatively low RSI of 45.589, indicating it is neither overbought nor oversold. However, the forward P/E ratio is 0, suggesting that the company is not expected to generate earnings in the near future, which is a significant concern for long-term investors. Additionally, the net income has decreased significantly to 290,121 in Q2 2026 from 3,656,457 in Q3 2024, indicating declining profitability. The main risk is the current ratio of 0.05, which shows that the company may struggle to meet its short-term liabilities.

バリュエーション指標

The current forward P/E ratio for GP-Act III Acquisition Corp (GPAT) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued

5Y Average P/E

0.00

Current P/E

0.00

割高

0.00

割安

0.00

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

割高

0.00

割安

0.00

Forward P/S

Fair

5Y Average P/S

0.03

Current P/S

0.00

割高

0.62

割安

-0.56

Alphio AI Price Scenarios for GPAT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%GPAT

$10.98

シナリオ価格

B

Base

Base · 50%GPAT

$9.46

シナリオ価格

B

Bear

Bear · 25%GPAT

$8.29

シナリオ価格

Whales holding GPAT

P

Polar Asset Management Partners Inc.

+ HoldingGPAT

+2.77%

3M Return

GPAT FAQ — answered by Alphio AI

GP-Act III Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.

Currently, GP-Act III Acquisition Corp. is not a good buy. The stock's current price is 10.95, and it has a relatively low RSI of 45.589, indicating it is neither overbought nor oversold. However, the forward P/E ratio is 0, suggesting that the company is not expected to generate earnings in the near future, which is a significant concern for long-term investors. Additionally, the net income has decreased significantly to 290,121 in Q2 2026 from 3,656,457 in Q3 2024, indicating declining profitability. The main risk is the current ratio of 0.05, which shows that the company may struggle to meet its short-term liabilities.